GEHCV GE HEALTHCARE TECHNOLOGIES INC

GE HealthCare showcases commitment to sustainable innovation at RSNA 2024

As part of a companywide commitment to advance innovation that improves the health of patients and the planet, GE HealthCare (Nasdaq: GEHC) is highlighting several solutions with increased focus on sustainability at the Radiological Society of North America (RSNA) 2024 Annual Meeting, which is held Dec. 1-4 in Chicago, IL.

“With a deep appreciation for the importance of sustainability, at GE HealthCare, we are managing our environmental footprint by integrating sustainability into our business while also decreasing operational costs through energy efficiency and waste reduction," said Roland Rott, president and CEO of Imaging, GE HealthCare. “More than one billion patients worldwide are touched by one of our products or care solutions annually – a responsibility we take very seriously as the actions we take now will impact our planet and global population for decades and centuries to come.”

Since becoming an independent company, GE HealthCare has continued to strengthen its legacy of improving the quality of life of people around the world. In 2023, the company reduced its overall greenhouse gas emissions by 13% as part of a strategy validated by the Science Based Targets initiative that seeks to achieve net zero carbon emissions by 2050. Additionally, that same year, the company also recovered 7,375 imaging, ultrasound, and surgery machines, leading to more than 15 million pounds of reused and recycled material.

Circulatory and environmentally conscious design

Through initiatives like the Circularity and Environmentally Conscious Design program, GE HealthCare works to extend the lifespan of products to serve customers and patients for as long as possible. For example, in many cases, magnetic resonance imaging (MRI) scanner magnets can be kept in place during equipment upgrades, eliminating the need for a new magnet and reducing the environmental impact associated with manufacturing and transportation. When some systems have reached the end of their lifecycle, dedicated teams may be available to manage the recycling and refurbishing to help keep waste out of landfills.

Sustainable innovations in remote scanning and pharmaceutical diagnostics

GE HealthCare also offers technologies that enable remote clinician training and remote patient scanning, such as Digital Expert Access with remote scanning and nCommand Lite by IONIC Health (exclusively distributed by GE HealthCare), which help support sustainability initiatives of hospitals and health systems.

“By leveraging more remote collaboration and scanning options, such as Digital Expert Access and nCommand Lite by IONIC Health, radiology administrators can streamline workflows and increase efficiency,” said Rekha Ranganathan, senior vice president, general manager, Imaging Platforms and Digital Solutions, GE HealthCare. “Having an expert technologist who can support the optimization of scan parameters, as well as improve throughput and reduce patient rescans, could also contribute to energy efficiency in healthcare systems.”

In the pharmaceutical diagnostics space, the CT motion™ syringeless power injector for iodinated contrast media improves patient throughput and greatly reduces overall plastic waste and contrast waste through optimizing contrast administration. A large academic hospital, University of Wisconsin - Madison, compared CT motion with a typical syringe-based injector and found it reduced their plastic waste by 84.6% (~3 tons) and eliminated their contrast media waste (31.3L) over the course of 16 weeks.i*

Additionally, in October, GE HealthCare announced the completion of its clinical development program for a first-of-its-kind manganese-based macrocyclic MRI contrast agent. Along with its suitable image-enhancing properties, this manganese-based agent could be a viable option to gadolinium, particularly in light of perceived concerns relating to gadolinium retention and the potential impact of post-patient excreted gadolinium in the environment.

Supporting sustainability across the GE HealthCare portfolio

During RSNA, GE HealthCare is featuring innovations designed with sustainability in mind, including:

  • CT motion & MR Max 3™ syringeless power injectors for the CT and MR radiology suite, compatible with multiple contrast container sizes and/or concentrations. These syringeless injectors enhance workflow efficiency, lower plastic waste consumption, and enable contrast optimization through the efficient use of Imaging Bulk Packaging containers, thus further reducing overall departmental cost by reducing contrast waste.
  • SIGNA™ Champion this system is GE HealthCare’s smallest footprint and most power efficient 1.5T wide bore system. Enabling shorter scans times, the system reduces power demands, increases throughput, and enhances the overall patient experience. With its highly scalable platform, SIGNA Champion supports broader affordability, configurability, and upgradability to support services expansion for health systems.
  • Vscan Air this ultrasound system is designed to be refurbished, reused, or recycled at the end of its product life to minimize unnecessary waste. The product is manufactured in GE HealthCare’s Zipf, Austria, a facility that uses 100% renewable electricity.
  • Revolution™ Apex platform – now boasts Energy Saving Mode 2.0, which transitions the scanner into low power mode during extended periods of non-operation to help reduce power consumption by approximately 80% in unit kW, and can achieve over a 30% reductionii in daily energy consumption (in kWh).
  • Revolution™ Ascend platform and Revolution™ Maxima these CT systems within the Revolution family reduce energy consumption by up to 15% and lower indirect carbon emissions by 68% when using energy savings mode.
  • AMX™ Navigateiii this X-ray system battery charges from 0% to 100% in 4.5 hours and can take up to 350 images over 4.6 hours without being plugged into a power outlet.
  • Omni Legend PET/CT this system, when idle, reduces energy consumption by up to 50% when using the standby power mode. In addition, the replacement X-ray tube for the Revolution Maxima can recycle 47% of the mass of the X-ray tube, enabling savings on energy and natural resources.

Sustainability beyond RSNA

In addition to the products being showcased at RSNA, GE HealthCare is furthering its commitment to sustainability by pioneering new breakthroughs to lead the green anesthesia movement. Gasses commonly used for anesthesia are recognized greenhouse gasses that contribute to global warming and can damage the Earth’s ozone layer, and according to the American Association of Nurse Anesthesiology, one-quarter of a hospital’s operating room waste is from anesthesiaiv. GE HealthCare’s End-tidal Control** software automatically adjusts and maintains exhaled oxygen and exhaled anesthetic concentrations, with more accuracy in reaching the clinician’s target versus manual control. By significantly reducing anesthetic agent usage, End-tidal Control can help reduce greenhouse gas emissions and costs, compared to conventional manual control. One study showed a potential 44% decline in the rate of greenhouse emissions when employing End-tidal Control software.v

For more information on GE HealthCare’s sustainability initiatives, and these innovative solutions showcased at RSNA, please visit Booth 7330, the company’s or the .

*Results are unique to UW-Madison's analysis and may not be extrapolated or generalized to other settings.

**End-tidal Control in the United States is indicated for patients 18 years of age and older.

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.

Follow us on , , , , and for the latest news, or visit our website for more information.

________________________________________

i
Toia GV, Rose SD, Brown Z, Dovalis D, Bartels CM, Bladorn RM, Schluter KL, Lubner MG, Szczykutowicz TP. Consumable Material Waste and Workflow Efficiency Comparison Between Multi-use Syringeless and Single-use Syringe-Based Injectors in Computed Tomography. Acad Radiol. 2023 Oct;30(10):2340-2349. doi: 10.1016/j.acra.2023.05.038. Epub 2023 Jun 26. PMID: 37380534.

ii Energy saving 2.0 according to the COCIR SRI 2015 for CT, which simulate 24 hours of daily use with 20 patients scans and 12 hours in low power mode.

iii AMX Navigate Data Sheet, data on file ()

iv

v Tay S, Weinberg L, Peyton P, Story D, Briedis J. Financial and environmental costs of manual versus automated control of end-tidal gas concentrations. Anaesthesia Intensive Care. 2013 Jan;41(1):95-101. doi:10.1177/0310057X1304100116. PMID: 23362897.

EN
04/12/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on GE HEALTHCARE TECHNOLOGIES INC

 PRESS RELEASE

GE HealthCare launches AI-driven, patient-friendly Invenia ABUS Premiu...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) announced the launch of Invenia™ Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound offering advanced artificial intelligence (AI) and innovative features to drive faster*, reproducible supplemental screening and streamline exam readings on patients with dense breasts. Approximately 71% of cancers occur in dense breasts.1 According to studies across the U.S. and Europe, 40% of women2 and 70% of Asian women3 have dense breast tissue, making them four to six times more likely to receive a breast cancer diagnosis.4 Early d...

 PRESS RELEASE

GE HealthCare and NVIDIA reimagine diagnostic imaging with autonomous ...

SAN JOSE, Calif.--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced a collaboration with NVIDIA at GTC 2025, expanding the existing relationship between the two companies to focus on pioneering innovation in autonomous imaging, beginning with autonomous X-ray technologies and autonomous applications within ultrasound. GE HealthCare has been at the forefront of medical technology innovation with a series of “firsts” that date back more than a century, starting with the invention of its X-ray tube, followed by several others including the first handheld ultrasound, first 3D obstetr...

 PRESS RELEASE

GE HealthCare expands invasive cardiology solutions portfolio with Alt...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced the launch of the AltiX AI.i edition of Mac-Lab™, CardioLab™ and ComboLab™. The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. These latest editions offer new features that can streamline workflow and enhance interoperability, while upholding strong cybersecurity standards. Cardiovascular disease (CVD) has nearly doubled over the past three decades, affecting more than 500 ...

 PRESS RELEASE

GE HealthCare Advances Its Cloud Strategy by Unveiling the Genesis Por...

LAS VEGAS--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced its new Genesis solutions, a portfolio of cloud enterprise imaging software-as-a-service (SaaS) solutions. Four features will be offered when commercially released – edge, storage, vendor neutral archive and data migration.i These cloud solutions, are designed to help enhance healthcare organizations’ efficiency and precision, streamline workflows, and optimize the use of capital and IT resources. The growing volume and complexity of patient cases are putting increasing pressure on hospitals’ IT systems, driving the ne...

 PRESS RELEASE

GE HealthCare names new president and CEO, China

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC), a leading global healthcare solutions provider, today announced that Yihao Zhang, president and CEO, China, will retire from the company effective July 1, 2025. Will Song, a Johnson & Johnson veteran for over 20 years, has been named GE HealthCare’s new president and CEO, China, and will join the company on April 1, 2025, ahead of leading the region starting July 1 following Yihao’s departure. Yihao’s planned retirement allowed GE HealthCare to purposefully identify and prepare a qualified successor in Will, an exceptional leader with ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch